Function & Fate of Alloantigen-specific CD8 Cell in GVHD
Function & Fate of Alloantigen-specific CD8 Cell in GVHD
批准号:
6624300
负责人:
PAUL J MARTIN
金额:
$30.28万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2006-03-31
关键词:
B lymphocyte T cell receptor antigen presenting cell bone marrow transplantation cell migration cell population study cytotoxic T lymphocyte flow cytometry genetically modified animals graft versus host disease helper T lymphocyte homologous transplantation immunofluorescence technique immunosuppressive inflammation interferon gamma isoantigen laboratory mouse leukocyte activation /transformation lymphopenia macrophage suppressor T lymphocyte tissue mosaicism
中文摘要
描述(申请人提供):以往移植物抗宿主研究
在动物模型和人类中的疾病(GVHD)一直受到以下困难的阻碍
根据供者T细胞群的能力识别供者T细胞群
识别受体同种异体抗原。这个问题已经通过开发一种
一种新的小鼠模型,在该模型中,可识别的供体CD8 T细胞群
识别受体同种异体抗原,并在功能上保持活跃
在体内长期致病后,收养转移到
受过致命照射的同种异体移植受者。初步研究结果如下:
显示T细胞受体对供者CD8的中等亲和力刺激
细胞会导致持续的GVHD,但高亲和力刺激会导致
流产的移植物抗宿主反应,在第14天达到顶峰,并在第二天消退
28例移植后。识别受体同种异体抗原的供体CD8细胞
在移植后第28天,脾和淋巴结中都有
移植物抗宿主反应流产的受者,表明
激活诱导的细胞凋亡并不能解决移植物抗宿主病。
在特定目标1中提出的实验将测试三个假设,这些假设可能
解释为什么供者CD8细胞对受者具有高亲和力的TCR
同种异体抗原不能引起持续性GVHD。供体CD8的高亲和力刺激
细胞可能导致效应器功能丧失,加速消除
受体抗原提呈细胞,或CD8效应细胞的异常迁移,
从而终止GVHD的进展。在具体建议中提出的实验
目的2评价炎症介质对供者CD8细胞的影响
导致移植物抗宿主病。以前的研究已经阐明了T细胞来源的作用
炎症细胞因子在导致GVHD的组织巨噬细胞激活中的作用
但最近的研究强调了炎性细胞因子的作用
关于激活的T细胞的生存和功能。实验已经被
旨在测试在存在炎症的情况下激活的假设
介体增强供体CD8细胞的存活率和功能
受体同种异体抗原,从而加剧了移植物抗宿主病的严重性。实验
在特定目标3中提出的将检验CD8反应的假设
从记忆细胞启动会导致比启动的反应更严重的GVHD
来自幼稚的细胞。在具体目标4中提出的实验旨在
测试CD4帮助将通过以下方式加重GVHD严重性的假设
增强CD8细胞的存活和功能。在这篇文章中提出的研究
应用程序将有助于澄清特定捐赠者的关键功能和命运
导致移植物抗宿主病的CD8细胞群。
英文摘要
DESCRIPTION (PROVIDED BY APPLICANT): Previous studies of graft-versus-host
disease (GVHD) in animal models and humans have been hampered by difficulty in
the identification of donor T cell populations according to their ability to
recognize recipient alloantigens. This problem has been solved by developing a
novel murine model in which an identifiable donor CD8 T cell population
recognizes a recipient alloantigen and remains functionally active and
pathogenic in vivo for a prolonged period of time after adoptive transfer into
lethally irradiated allogeneic recipients. Results of preliminary studies have
shown that intermediate avidity stimulation of T cell receptors on donor CD8
cells leads to sustained GVHD, but high avidity stimulation leads to an
abortive graft-versus-host response that peaked at day 14 and subsided by day
28 after the transplant. Donor CD8 cells that recognize a recipient alloantigen
were present in the spleen and lymph nodes on day 28 after the transplant in
recipients with an abortive graft-versus-host response, indicating that
activation-induced apoptosis did not account for the resolution of GVHD.
Experiments proposed in Specific Aim 1 will test three hypotheses that might
explain why donor CD8 cells having a TCR with high avidity for a recipient
alloantigen did not cause sustained GVHD. High avidity stimulation of donor CD8
cells might lead to loss of effector function, accelerated elimination of
recipient antigen-presenting cells, or altered migration of CD8 effector cells,
thereby terminating the progression of GVHD. Experiments proposed in Specific
Aim 2 will evaluate the effects of inflammatory mediators on donor CD8 cells
that cause GVHD. Previous studies have elucidated the role of T cell-derived
inflammatory cytokines in the activation of tissue macrophages leading GVHD,
but more recent studies have emphasized the effects of inflammatory cytokines
on the survival and function of activated T cells. Experiments have been
designed to test the hypothesis that activation in the presence of inflammatory
mediators enhances the survival and function of donor CD8 cells that recognize
recipient alloantigens, thereby exacerbating the severity of GVHD. Experiments
proposed in Specific Aim 3 will test the hypothesis that a CD8 response
initiated from memory cells leads to more severe GVHD than a response initiated
from naive cells. Experiments proposed in Specific Aim 4 have been designed to
test the hypothesis that CD4 help will exacerbate the severity of GVHD by
enhancing the survival and function of CD8 cells. The studies proposed in this
application will help clarify the critical functions and fate of specific donor
CD8 cell population that cause GVHD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protocol Review and Monitoring System
-
批准号:8804792
-
项目类别:
-
资助金额:$19.36万
-
财政年份:2015
-
负责人:PAUL J MARTIN
-
依托单位:
Clinical Protocol and Data Management
-
批准号:9001923
-
项目类别:
-
资助金额:$64.96万
-
财政年份:2015
-
负责人:PAUL J MARTIN
-
依托单位:
Patient Enrollment, Specimen and Data Management, and Biostatistics
-
批准号:8309107
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2011
-
负责人:PAUL J MARTIN
-
依托单位:
Long-Term Follow-up Core
-
批准号:8277828
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2011
-
负责人:PAUL J MARTIN
-
依托单位:
Prevention and Treatment of Graft-Versus-Host Disease
-
批准号:8277819
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2011
-
负责人:PAUL J MARTIN
-
依托单位:
EFFICACY OF CD28 ANTIBODY FOR GVHD PREVENTION
-
批准号:8172753
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2010
-
负责人:PAUL J MARTIN
-
依托单位:
Patient Enrollment, Specimen and Data Management, and Biostatistics
-
批准号:7676420
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2009
-
负责人:PAUL J MARTIN
-
依托单位:
EFFICACY OF CD28 ANTIBODY FOR GVHD PREVENTION
-
批准号:7958857
-
项目类别:
-
资助金额:$15.76万
-
财政年份:2009
-
负责人:PAUL J MARTIN
-
依托单位:
Core--Long-Term Follow-Up and Chronic GVHD
-
批准号:7478452
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2007
-
负责人:PAUL J MARTIN
-
依托单位:
Long-Term Follow-up Core
-
批准号:7240148
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2006
-
负责人:PAUL J MARTIN
-
依托单位:
Core--Long-Term Follow-Up and Chronic GVHD
-
批准号:7304878
-
项目类别:
-
资助金额:$18.33万
-
财政年份:2006
-
负责人:PAUL J MARTIN
-
依托单位:
Prevention and Treatment of Graft-Versus-Host Disease
-
批准号:7226428
-
项目类别:
-
资助金额:$26.7万
-
财政年份:2006
-
负责人:PAUL J MARTIN
-
依托单位:
Mycophenylate mofetil for treatment of chronic GVHD
-
批准号:6750645
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2003
-
负责人:PAUL J MARTIN
-
依托单位:
Mycophenylate Mofetil for Treatment of Chronic GVHD
-
批准号:7462527
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2003
-
负责人:PAUL J MARTIN
-
依托单位:
Mycophenylate mofetil for treatment of chronic GVHD
-
批准号:6931505
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2003
-
负责人:PAUL J MARTIN
-
依托单位:
Mycophenylate mofetil for treatment of chronic GVHD
-
批准号:7098018
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2003
-
负责人:PAUL J MARTIN
-
依托单位:
Mycophenylate mofetil for treatment of chronic GVHD
-
批准号:7226742
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2003
-
负责人:PAUL J MARTIN
-
依托单位:
Core--Long term follow-up and chronic GVHD
-
批准号:6794863
-
项目类别:
-
资助金额:$10.42万
-
财政年份:2003
-
负责人:PAUL J MARTIN
-
依托单位:
Mycophenylate mofetil for treatment of chronic GVHD
-
批准号:6561562
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2003
-
负责人:PAUL J MARTIN
-
依托单位:
Function & Fate of Alloantigen-specific CD8 Cell in GVHD
-
批准号:6726099
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2002
-
负责人:PAUL J MARTIN
-
依托单位:
海外基金